GlobeNewswire

Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update
11/11/2026
REYKJAVIK, ICELAND (November 11, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for [...]
Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update
11/11/2026
REYKJAVIK, Iceland, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar [...]
Solana Company Reports Third Quarter 2026 Financial Results
11/11/2026
PHILADELPHIA, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed digital asset treasury, infrastructure, and services company providing institutional access to [...]
Addex Spin-out Neurosterix Closes $105 Million Series B Financing
11/11/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, November 11, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
CORRECTION: Milestone Scientific Schedules Third Quarter 2026 Financial Results Conference Call
11/11/2026
In a release issued under the same headline earlier today by Milestone Scientific, Inc., please note that in the first paragraph of the release, the conference call date should have been Friday, November 13, not [...]
Juniper Biosciences Builds Clinical and Commercial Leadership Teams with Appointments of Deepak Behera, M.D., as Chief Medical Officer, Javed Mahmood, Ph.D., as Senior Director of Clinical Development, and Robert Sgroi as Chief Commercial Officer
11/11/2026
BEDMINSTER, N.J., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Juniper Biosciences ("Juniper" or "the Company"), a radiopharmaceutical drug development company, today announced the establishment of its clinical team with the [...]
Join Luma Named Cheapest Place to Buy Compounded Tirzepatide Online Among Seven Providers Compared for 2026
11/11/2026
Join Luma ranks most affordable in a seven-provider comparison, with compounded tirzepatide injections from $149 per month on qualifying prepaid plans and no separate membership fee BETHPAGE, N.Y., Nov. 11, 2026 (GLOBE [...]
Major shareholder announcement - BlackRock, Inc.
11/11/2026
ANNOUNCEMENT NO. 328 11 November 2026 Pursuant to section 30 of the Danish Capital Markets Act, notice is hereby given that BlackRock, Inc. has notified ChemoMetec A/S that, on 6 November 2026, BlackRock, Inc. increased [...]
MD Logic Health x Blu Vitals Launch First Collaboration Product, Mag 9+, a Breakthrough Nine-Form Magnesium Complex
11/11/2026
Miami, FLORIDA, Nov. 11, 2026 (GLOBE NEWSWIRE) -- MD Logic Health® is collaborating with Blu Vitals, its newest cobrand, to introduce Mag 9+, the first product from the partnership. Blu Vitals is a longevity-focused [...]
PETVIVO HOLDINGS TO FILE QUARTERLY REPORT ON NOVEMBER 13, 2026; WELCOMES SHAREHOLDER QUESTIONS AND DIALOGUE
11/11/2026
MINNEAPOLIS, Nov. 11, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV) ("PetVivo" or the “Company”), a biomedical device company focused on the commercialization of innovative medical devices and [...]
Maxim Hair Restoration Partners With TrichoLAB to Bring 3D Planning to Its Hair Transplant Consultations
11/11/2026
Through the partnership, patients at select Maxim Hair Restoration clinics can now see a 3D preview of their planned hairline and graft placement before surgery, using TrichoLAB's 3D Studio and 3D Transplanner [...]
Channel Medsystems Announces Grant Support for an Investigator-Sponsored Clinical Study Evaluating Cerene® Cryotherapy for Women With Adenomyosis
11/11/2026
BERKELEY, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Channel Medsystems, Inc., a privately held medical technology company dedicated to raising the standard of care for women with heavy menstrual bleeding and [...]
Whitecap Care’s Autism First Joins National Integrated Therapy Provider
11/11/2026
WARRENTON, Va., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Whitecap Care , a leading provider of innovative healthcare services and dedicated to providing advanced, compassionate healthcare services that meet the evolving needs [...]
CHARM Therapeutics and Collaborator Dr. Florian Perner to Present Compelling Data Showing the Potential of Next-Generation Menin Inhibitors to Deliver More Durable Responses for AML at the 8th ASH Annual Meeting
11/11/2026
LONDON – 11 November 2026 -- CHARM Therapeutics (“CHARM”, “The Company”), a clinical-stage biotechnology company addressing resistance in acute myeloid leukemia (AML) with a best-in-class menin inhibitor, today [...]
Horizon Europe-funded HERMOD project launches to support Phase 2 development of HER-096 in Parkinson’s disease
11/11/2026
Espoo, Finland, 11 November 2026: Herantis Pharma Plc (“Herantis”), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, today announces that the Horizon Europe [...]
AC Immune to Present at Jefferies Global Healthcare Conference 2026
11/11/2026
AC Immune to Present at Jefferies Global Healthcare Conference 2026 Lausanne, Switzerland, November 11, 2026 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharma company targeting the key pathologic misfolded [...]
CDT Commences Human Skin Studies with QIMA Life Sciences on Novel Tapinarof Combinations in Vitiligo
11/11/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Nov. 11, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced that studies have commenced with QIMA Life Sciences, a world leading [...]
Nkarta Presents Initial Safety Data for NKX019 in 40 Patients Across Five Autoimmune Diseases at ACR Convergence 2026
11/11/2026
No cases of cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS), or graft-versus- [...]
Sinaptica Therapeutics to Host Scientific Symposium at CTAD 2026 Exploring the Role of Brain Network Dysfunction in Alzheimer's Disease
11/11/2026
Leading Alzheimer's researchers Giacomo Koch, Emiliano Santarnecchi and Harald Hampel to examine emerging evidence, biomarkers and therapeutic approaches targeting brain network dysfunction Scientific co-founder Giacomo [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum